Sosei Bolsters GPCR Focus With AbbVie Neurology Deal
Gets $40m Upfront
The Japanese firm has expanded its partnership with AbbVie into the neurology space, where it hopes to use its unique platform technology to develop up to three drug candidates targeting ‘challenging’ G protein-coupled receptor targets.
